Literature DB >> 16166251

Gene-expression profiling of CD34+ hematopoietic cells expanded in a collagen I matrix.

Joachim Oswald1, Christine Steudel, Katrin Salchert, Brigitte Joergensen, Christian Thiede, Gerhard Ehninger, Carsten Werner, Martin Bornhäuser.   

Abstract

CD34+ hematopoietic stem/progenitor cells (HSCs) reside in the bone marrow in close proximity to the endosteal bone surface, surrounded by osteoblasts, stromal cells, and various extracellular matrix molecules. We used a bioartificial matrix of fibrillar collagen I, the major matrix component of bone, as a scaffold for ex vivo expansion of HSCs. CD34+ HSCs were isolated from umbilical cord blood and cultivated within reconstituted collagen I fibrils in the presence of fms-like tyrosine kinase-3 ligand, stem cell factor, and interleukin (IL)-3. After 7 days of culture, the cell number, number of colony-forming units (CFU-C), and gene-expression profile of the cultured cells were assessed. Although the total expansion factor of CD34+ cells was slightly lower when cells were cultivated in the collagen I gel, the frequency of CFU-C was greater than in control suspension cultures. Gene-expression analysis with microarray chip technology revealed the upregulation of more than 50 genes in the presence of collagen I. Among these, genes for several growth factors, cytokines, and chemokines (e.g., IL-8 and macrophage inhibitory protein 1alpha) could be confirmed using quantitative polymerase chain reaction. Furthermore, greater expression levels of the negative cell-cycle regulator BTG2/TIS21 and an inhibitor of the mitogen-activated protein kinase pathway, DUSP2, underline the regulatory role of the extracellular matrix. Together, these data show that the expansion of CD34+ cord blood cells in a culture system containing a three-dimensional collagen I matrix induces a qualitative change in the gene-expression profile of cultivated HSCs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16166251     DOI: 10.1634/stemcells.2005-0276

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  33 in total

1.  Compatibility of different polymers for cord blood-derived hematopoietic progenitor cells.

Authors:  Mónica Ventura Ferreira; Norina Labude; Daniela Piroth; Willi Jahnen-Dechent; Ruth Knüchel; Thomas Hieronymus; Martin Zenke; Sabine Neuss
Journal:  J Mater Sci Mater Med       Date:  2011-11-10       Impact factor: 3.896

2.  Maintenance and expansion of hematopoietic stem/progenitor cells in biomimetic osteoblast niche.

Authors:  Jing Tan; Ting Liu; Li Hou; Wentong Meng; Yuchun Wang; Wei Zhi; Li Deng
Journal:  Cytotechnology       Date:  2010-09-10       Impact factor: 2.058

3.  Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase.

Authors:  Li Zhou; Christine McMahon; Tushar Bhagat; Cristina Alencar; Yiting Yu; Melissa Fazzari; Davendra Sohal; Christoph Heuck; Krishna Gundabolu; Chun Ng; Yongkai Mo; Wa Shen; Amittha Wickrema; Guanghui Kong; Ellen Friedman; Lubomir Sokol; Ioannis Mantzaris; Giannis Mantzaris; Andrea Pellagatti; Jacqueline Boultwood; Leonidas C Platanias; Ulrich Steidl; Lei Yan; Jonathan M Yingling; Michael M Lahn; Alan List; Markus Bitzer; Amit Verma
Journal:  Cancer Res       Date:  2010-12-28       Impact factor: 12.701

Review 4.  Biomaterials approach to expand and direct differentiation of stem cells.

Authors:  Chou Chai; Kam W Leong
Journal:  Mol Ther       Date:  2007-01-30       Impact factor: 11.454

5.  In vitro analog of human bone marrow from 3D scaffolds with biomimetic inverted colloidal crystal geometry.

Authors:  Joan E Nichols; Joaquin Cortiella; Jungwoo Lee; Jean A Niles; Meghan Cuddihy; Shaopeng Wang; Joseph Bielitzki; Andrea Cantu; Ron Mlcak; Esther Valdivia; Ryan Yancy; Matthew L McClure; Nicholas A Kotov
Journal:  Biomaterials       Date:  2008-11-29       Impact factor: 12.479

Review 6.  Enabling stem cell therapies through synthetic stem cell-niche engineering.

Authors:  Raheem Peerani; Peter W Zandstra
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

7.  The Stromal Activity of Mesenchymal Stromal Cells.

Authors:  Wolfgang Wagner; Rainer Saffrich; Anthony D Ho
Journal:  Transfus Med Hemother       Date:  2008-05-16       Impact factor: 3.747

8.  In-vitro Behavior of Human Umbilical Cord Blood Stem Cells Towards Serum Based Minimal Cytokine Growth Conditions.

Authors:  Santwana Mantri; Praksh Chandra Mohapatra
Journal:  Indian J Clin Biochem       Date:  2013-05-29

9.  The KIDSTEM European Research Training Network: Developing a Stem Cell Based Therapy to Replace Nephrons Lost through Reflux Nephropathy.

Authors:  Patricia Murray; Giovanni Camussi; Jamie A Davies; David Edgar; Markus Hengstschlager; Simon Kenny; Giuseppe Remuzzi; Carsten Werner
Journal:  Organogenesis       Date:  2007-01       Impact factor: 2.500

10.  Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS.

Authors:  Li Zhou; Aaron N Nguyen; Davendra Sohal; Jing Ying Ma; Perry Pahanish; Krishna Gundabolu; Josh Hayman; Adam Chubak; Yongkai Mo; Tushar D Bhagat; Bhaskar Das; Ann M Kapoun; Tony A Navas; Simrit Parmar; Suman Kambhampati; Andrea Pellagatti; Ira Braunchweig; Ying Zhang; Amittha Wickrema; Satyanarayana Medicherla; Jacqueline Boultwood; Leonidas C Platanias; Linda S Higgins; Alan F List; Markus Bitzer; Amit Verma
Journal:  Blood       Date:  2008-05-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.